Term
what are some of the pharmacological sites of immune suppression? |
|
Definition
- GLUCOCORTICOIDS (inhibit gene expression)
- LEFLUNOMIDE/MTX (inhibit clonal expansion of lymphocytes)
- CYCLOSPORINE/TACROLIMUS (interrupt intracellular signals)
- ETANCERCEPT/ANAKINRA (cytokine blockers)
- ABATACEPT (inhibits costimulation of APCs)
- EFALUZIMAB (inhibit lymphocyte cell adhesion)
- COMPLEMENT INACTIVATION
|
|
|
Term
what are some of the intervention points of glucocorticoids to accomplish their immunosuppresive/anti-inflammatory role? |
|
Definition
- lymphocytes (to halt their cytokine secretion)
- endothelial cell adhesion molecules
- basophils (histamine/LT release)
- monocytes
|
|
|
Term
where do GCs intervene to block LTs? |
|
Definition
act on PLA or PLC, which is responsible for converting essential fatty acids into arachidonic acid |
|
|
Term
what are the systemic clinical uses of GCs? |
|
Definition
- to achieve adequate short term control for conditions like arthritis
- reduces chronic inflammation but there is also reduced healing
- problems occur with long term use, so only used chronically when other measures fail
|
|
|
Term
what are the hematological and immunological side effects of GC therapy? |
|
Definition
- reduced number of cells (eosinophils, leukocytes, lymphocytes)
- altered inflammatory response
|
|
|
Term
what are the GI and metabolic/musculoskeletal side effects of GC therapy? |
|
Definition
GI:
- fatty liver
- peptic ulceration
Metabolic/musculoskeletal
- protein wasting
- hyperlipidemia
- obesity (increased abdominal fat, buffalo hump)
- avascular necrosis of femoral head
- osteoporosis
|
|
|
Term
what are the ocular and CNS side effects of GC therapy? |
|
Definition
ocular:
- cataracts
- increased intraocular pressure
CNS:
|
|
|
Term
what are the fluid/electrolyte and endocrinologic side effects of GC therapy? |
|
Definition
fluid/electrolyte
- Na+ retention
- hypertension
endocrinologic
- H-P suppression (hypothalamo-pituitary axis)-->decreased libido among others...
|
|
|
Term
what are the skin and general side effects of GC therapy? |
|
Definition
skin
- striae
- hirsutism
- thinning
general
|
|
|
Term
among the various GCs, how do they differ? |
|
Definition
- affinity to GC-Rec
- anti-inflammatory potency
- Na retention
- duration (oral/IV)
prednisone, hydrocortisone, prednisilone are all low receptor affinity GCs--> low anti-inflammatory potency |
|
|
Term
name a few uses of systemic GCs. |
|
Definition
- asthma
- bee sting
- IBD
- arthritis
- cerebral edema (post op)
- dermatitis
- conjunctivitis
|
|
|
Term
what are the main topical uses of GCs? |
|
Definition
- asthma and other non-infectious URIs
- allergic and non-allergic rhinitis
goal: reduce vasodilation and fluid exudation
toxicity: minimal; candidiasis at worst; rarely adrenal insufficiency |
|
|
Term
what cytokines do CD4+ cells secrete and how do they operate in the pathway towards rheumatoid arthritis? |
|
Definition
CD4+ cells secrete:
These cytokines stimulate:
- B cells --> plasma cells --> rheumatoid factor --> immune complex --> CARTILAGE & BONE DAMAGE
- Macrophages -->
- IL-1
- TNF a
- IL 6
- IL 8 -->
- OSTEOCLASTS, FIBROBLASTS, AND ENDOTHELIAL CELLS --> CARTILAGE & BONE DAMAGE
|
|
|
Term
what is methotrexate and what is its mechanism of action? |
|
Definition
- MTX: DMARD of choice with low side effects
- purine synthesis inhibitor via AICAR-T/thymidylate synthase inhibition
- directly inhibits B CELL PROLIFERATION
- end result: less pro-inflammatory and more anti-inflammatory cytokines
|
|
|
Term
what are the common ADRs of MTX and what are its most important contraindications? |
|
Definition
- ADRs:
- mostly GI
- require folic acid supp
- Contraindications:
- pregnancy + breast feeding (anti-mitotic)
- major organ disease (xcpt heart)
- XS EtOH
- immune disorders
- blood dyscrasias
- Use:
|
|
|
Term
what is the mechanism of leflunomide and what is special about its administered form? |
|
Definition
leflunomide is a pro-drug that must be activated by the liver
it is a pyridimine synthesis inhibitor (preventing cell division; cells arrest in G1 blocking T cell prolif)
also blocks TNF-dependent NK-kB activation
|
|
|
Term
what are the ADRs and contraindications for leflunomide? |
|
Definition
- ADRs:
- diarrhea and other GI disturbances
- Contraindications:
- pregnancy or perinatal use (2 years)
- care with other drugs (long half life)
- Use:
|
|
|
Term
what is the mechanism and pharmanokinetic profile of hydrochloroquine as tx for RA? |
|
Definition
- mechanism: unclear
- pharmacokinetics: SLOW ONSET, used as long term therapy
- metabolism: takes a while to excrete, esp with chronic use; concentrates in various organs
- ADRs: leukopenia, hazy vision due to corneal depositions, photophobia
- use: when other drugs fail for RA and SLE
|
|
|
Term
how does auranofin (gold) work and in what cases is it indicated? |
|
Definition
- mechanism: multiple suspected
- ADRs: high incidence (25-50% pts); dermatoses, mucous lesions, blood dyscrasias, hepatitis, encephalitis, nephritis
- contraindications:renal failure, elderly with poor toleration; MONITORING req'd
- use: oral only (auranofin is soluble drug), in active rapidly progressing cases of RA when nothing else is working; affects long remissions (and when they do occur tend to be less severe)
|
|
|
Term
what are the 3 TNF-a binding biological response modifiers? |
|
Definition
- adalimumab
- infliximab
- etanercept
|
|
|
Term
what is adalimumab's mechanism of action? |
|
Definition
- mechanism: rH mAb that binds soluble TNFa --> downregulates macrophage and T cell function
- ADRs: opportunistic infections (ie: TB); increases ANA (antinuclear ab test...but no sign of lupus)
- use: sc q2w for RA with MTX
|
|
|
Term
what are the inflammatory cytokines stimulated by macrophage-released TNF a? |
|
Definition
- IL 1
- IL 6
- IL 8
- more TNF a
|
|
|
Term
what is the mechanism of infliximab? |
|
Definition
- chimeric mAb binds to soluble & membrane bound TNFa
- ADRs: URIs (flu like), latent TB may surface, + ANA
- Use: iv in RA q8w with MTX; also used for ulcerative colitis and other arthritides
|
|
|
Term
what is the mechanism of etanercept? |
|
Definition
- 2 rTNFRs that bind 2 soluble TNFa/b's
- ADRs: erythema, pain, itching, headaches, and opportunistic infections, + ANA (many sxs look like an allergic rxn)
- use: sc twice weekly in RA, AS, JA, often with MTX
|
|
|
Term
what is the mechanism of anakinra? |
|
Definition
- anakinra is IL 1Ra (antagonist) that blocks IL 1 binding to its receptor
- ADRs: injection site, opportunistic infections
- use: sc qd in moderate to severe RA alone or with MTX and others
relatively long t1/2 enables less frequent dosing |
|
|
Term
where are H1 receptors primarily found? |
|
Definition
- lung --> asthma
- nasal epithelia --> sinus inflammation, hay fever
- skin (face) --> dermatitis, eczema, hives, allergic conjunctivitis
|
|
|
Term
what are some of the actions of histamine on H1 receptors? |
|
Definition
- bronchial, bronchiolar constriction
- ileal smooth muscle constriction
- increased vascular permeability
- vasodilation
|
|
|
Term
what are the off label uses of antihistamines? |
|
Definition
- sedatives/hypnotics
- local anesthesia
|
|
|
Term
what molecular structure do H1 histamine antagonists resemble? |
|
Definition
H1 histamine antagonists resemble cholinergic agonists
NOT similar in structure to histamine
*H2 antagonists resemble histamine* |
|
|
Term
what are the major pharmacodynamic characteristics of H1 histamine RAs? |
|
Definition
- first generation H1 RAs:
- sedating (early>late)
- anticholinergic (muscarinic)
- anti-emetic/antimotion sickness
- short half lives
- second generation:
- generally lack CNS effects
- longer half lives
|
|
|
Term
what is the clinical utility of H1 antagonists? |
|
Definition
- conjunctivitis
- hay fever
- mild sleep disorder
- motion sickness
- pruritis
- rhinitis
- urticaria (hives)
|
|
|
Term
when are H1 antags ineffective? |
|
Definition
- once histamine already bound
- anaphylactic rxns
- chronic sinusitis
- asthma
|
|
|
Term
what are the major side effects of H1 antags? |
|
Definition
- CNS depressant effects:
- dizziness, fatigue, sedation
- additive with other CNS depressans (EtOH)
- antimuscarinic effects:
- dryness, blurred vision, constipation, urinary retention
- tachycardia, CNS excitation-->convulsions
|
|
|
Term
what is the drug profile of DIPHENHYDRAMINE? |
|
Definition
- effective in motion sickness (but sedating)
- anti-nauseant
- contraindications:
- BPH (bc of urine retention)
- glaucoma
- operation of machinery
- duration: around 4 hrs
|
|
|
Term
what is the drug profile of DIMENHYDRINATE? |
|
Definition
- antimuscarinic = diphenhydramine
|
|
|
Term
what is the drug profile of CHLORPHENIRAMINE? |
|
Definition
- late first gen H1 antag
- antihistaminic
- slightly sedative (dose dept)
- slightly antimuscarinic
trade name: chlor-trimeton/dimetane |
|
|
Term
what is the drug profile of CETIRIZINE (ZYRTEC)? |
|
Definition
- no antimuscarinic
- little or no sedation
- BID
- 2nd gen
other similar drugs:
- loratidine (claritin)
- fexofenadine (allegra)
|
|
|
Term
what is the drug profile of ZILEUTON? |
|
Definition
- INHIBITS 5-LIPOX PATHWAY
- ASTHMA TX
- CONTRAINDICATIONS:
- breast feeding, pregnant, or soon to be
- hepatic disease
- other meds
- EtOH
- Leukotriene inhibitor
|
|
|
Term
what is the drug profile of ZAFIRLUKAST? |
|
Definition
- ZAFIRLUKAST/MONTELUKAST (ACCOLATE/SINGULAIR): LT ANTAGONISTS
- 2-FOLD INCREASE IN FEV1 IN ASTHMATICS (SIMILAR EFFECT AS BECLOMETHASONE)
- ADRS:
- ABDOMINAL PAIN
- DIZZINESS
- HEADACHE
- RHINITIS
- SORE THROAT
|
|
|
Term
what is the drug profile of CROMOLYN? |
|
Definition
- prophylactic rx for upper respiratory tract
- multiple mechanisms
|
|
|